These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 337266)

  • 21. Antihypertensive effect of atenolol--a Swedish multicentre study.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Postgrad Med J; 1977; 53 Suppl 3():98. PubMed ID: 337274
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the hypotensive effect of atenolol].
    Sznajderman M; Brym E; Cybulska I; Czerniewska E; Niegowska J
    Kardiol Pol; 1979; 22(6):661-6. PubMed ID: 393889
    [No Abstract]   [Full Text] [Related]  

  • 24. Atenolol as additive therapy in hypertension.
    Jones BP; Ingram DF; Mason B; Barker NP
    Practitioner; 1978 Jan; 220(1315):149-52. PubMed ID: 343089
    [No Abstract]   [Full Text] [Related]  

  • 25. Atenolol in hypertension.
    Misra NP; Bahadur MM
    J Assoc Physicians India; 1984 Oct; 32(10):863-6. PubMed ID: 6394581
    [No Abstract]   [Full Text] [Related]  

  • 26. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernández-Pieretti O
    Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of once and twice daily atenolol in hypertension.
    Castleden CM; Dathan JR; George CF
    Postgrad Med J; 1977 Nov; 53(625):679-82. PubMed ID: 339214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics.
    Majid PA; van der Vijgh WJ; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    Eur J Cardiol; 1979 Jun; 9(6):419-35. PubMed ID: 381009
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
    Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
    Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the combination of atenolol and indapamide in the therapy of arterial hypertension (with data concerning toxicity and tolerance in the experimental animal)].
    Anania V; Bartoli E; Desole MS; Faedda R; Miele E; Olmeo NA; Satta A; Soggia G; Vacca R
    Clin Ter; 1981 Jul; 98(1):11-23. PubMed ID: 7249570
    [No Abstract]   [Full Text] [Related]  

  • 32. [Systolic-diastolic function of the left ventricle and flowmetry of the lower limbs in the treatment of moderate essential arterial hypertension with atenolol-chlorthalidone].
    Franchi F; Bisi G; Fabbri G; Pedenovi P; Lo Sapio P; Matassi L; Righi D; Galanti G
    Minerva Cardioangiol; 1986 Sep; 34(9):567-77. PubMed ID: 3543732
    [No Abstract]   [Full Text] [Related]  

  • 33. Antihypertensive effect of atenolol (100 mg once a day) and methyldopa (250 mg thrice a day). A double-blind cross-over multicentre study.
    Kristensen BO; Brøns M; Christensen CK; Geday E; Jacobsen FK; Jensen SN; Linde NC
    Acta Med Scand; 1981; 209(4):267-70. PubMed ID: 7015798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC; Rosenthal J; Stumpe KO
    Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Normalization of ventricular compliance and hypertrophy in arterial hypertension. Double-blind study with 2 combinations of a beta blocker and diuretic].
    Mohallen KL; do Patrocínio LL; Célnik D; Kruczan DD; Pinheiro L; Weitzel LH; Bosco J; Sekeff JA; Azevedo Ade C
    Arq Bras Cardiol; 1987 Jun; 48(6):345-50. PubMed ID: 2965568
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
    Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C
    Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.